CarlBartonShanholtzMD

Pulmonology • Baltimore, MD

Critical Care Medicine

Professor, Medicine, University of Maryland School of Medicine

Join to view full profile

Dr. Shanholtz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shanholtz's full profile

Already have an account?

Office
110 South Paca St.
2nd Floor
Baltimore, MD 21201
Phone+1 410-328-8141

Fax+1 410-328-0177

Education & Training

Naval Medical Center (San Diego)Internship, Internal Medicine, 1983 - 1984
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1983

Certifications & Licensure

MD State Medical License 1989 - 2025
PA State Medical License 1984 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine

Clinical Trials

Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®) Start of enrollment: 2012 Jul 01
Completed
Not Applicable
Managing Acute Pain in Critically Ill Non-communicative Palliative Care Patients Start of enrollment: 2015 Mar 01
Completed
Not Applicable
Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER) Start of enrollment: 2020 Jul 24
Active, not recruiting
Phase 1

Publications & Presentations

PubMed

395 citations
Physical complications in acute lung injury survivors: a two-year longitudinal prospective study.
Eddy Fan, David W. Dowdy, Elizabeth Colantuoni, Pedro A. Mendez-Tellez, Jonathan E. Sevransky
Critical Care Medicine. 2014-04-01
371 citations
Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome
Jonathon D. Truwit, Gordon R. Bernard, Jay S. Steingrub, Michael A. Matthay, Kathleen D. Liu
The New England Journal of Medicine. 2014-06-04
178 citations
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis
Mark M. Wurfel, Anthony C. Gordon, Tarah D. Holden, Frank Radella, Jeanna Strout
American Journal of Respiratory and Critical Care Medicine. 2008-10-01

Abstracts/Posters

Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti...
Carl Shanholtz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

ECMO for Severe Acute Respiratory Distress SyndromeSeptember 12th, 2018